{
    "eid": "2-s2.0-85159009585",
    "title": "Practices and challenges for hemophilia management under resource constraints in Thailand",
    "cover-date": "2023-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Genetics (clinical)",
            "@code": "2716",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Clotting factor concentrates",
        "Coagulation factor",
        "Healthcare rationing",
        "Hemophilia",
        "Hemophilia A",
        "Hemophilia B",
        "Thailand"
    ],
    "authors": [
        "Chatphatai Moonla",
        "Darintr Sosothikul",
        "Bunchoo Pongtanakul",
        "Bundarika Suwanawiboon",
        "Chanchai Traivaree",
        "Rungrote Natesirinilkul",
        "Nongnuch Sirachainan",
        "Pantep Angchaisuksiri"
    ],
    "citedby-count": 0,
    "ref-count": 14,
    "ref-list": [
        "WFH guidelines for the management of hemophilia",
        "Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres",
        "Epidemiology & social costs of haemophilia in India",
        "Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management",
        "Efficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society",
        "Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study",
        "Effectiveness of monthly low dose emicizumab prophylaxis without 4-week loading doses among patients with haemophilia A with and without inhibitors: a case series report",
        "Real-world evidence on health resource use among patients with haemophilia and inhibitor exhibiting severe bleeding episodes",
        "Mobile health technology for the personalized therapy of hemophilia",
        "Impact of novel hemophilia therapies around the world",
        "Efanesoctocog alfa prophylaxis for patients with severe hemophilia A",
        "The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A",
        "Direct transfer of data of people with haemophilia from the Thai Haemophilia Treatment Centre Registry to the World Bleeding Disorders Registry of the World Federation of Hemophilia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Pfizer Ltd.",
        "Rachadapiseksompotch Fund",
        "Medical Center of Excellence",
        "Chulalongkorn University"
    ]
}